We are live on ! Find out more
LABU icon

Direxion Daily S&P Biotech Bull 3X ETF
LABU

43 hedge funds and large institutions have $51.9M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2024 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 7 increasing their positions, 17 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 7

60% more call options, than puts

Call options by funds: $123M | Put options by funds: $77.1M

19% more funds holding

Funds holding: 36 → 43 (+7)

0.13% more ownership

Funds ownership: 5.34% → 5.48% (+0.13%)

9% less capital invested

Capital invested by funds: $56.8M → $51.9M (-$4.89M)

59% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 17

Holders
43
Holders Change
+7
Holders Change %
+19.44%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
7
Reduced
17
Closed
7
Calls
$123M
Puts
$77.1M
Net Calls
+$46.2M
Net Calls Change
+$14.9M

Top Buyers

Rank Fund Capital Flow
1
QC
Quadrature Capital
United Kingdom
+$9.41M
2
TI
Tidal Investments
Wisconsin
+$9.13M
3
CM
Cercano Management
Washington
+$3.75M
4
GS
GTS Securities
New York
+$868K
5
Jane Street
Jane Street
New York
+$799K

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$7.7M
2
Citadel Advisors
Citadel Advisors
Florida
-$7.31M
3
HF
HRT Financial
New York
-$7.23M
4
TAA
TB Alternative Assets
Cayman Islands
-$4.57M
5
Squarepoint
Squarepoint
New York
-$3.05M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
26
Citigroup
New York
$102K -$41.1K -315 -28%
PA
27
Parallel Advisors
California
$84.3K -$58.1K -445 -40%
Bank of America
28
Bank of America
North Carolina
$77.8K -$7.7M -59,022 -99%
LC
29
Lindbrook Capital
California
$52.1K -$4.96K -38 -9%
DF
30
Dunhill Financial
United Kingdom
$46.3K +$47K +360 New
TSMHT
31
Thurston Springer Miller Herd & Titak
Indiana
$43.4K +$44K +337 New
HI
32
Hoey Investments
Pennsylvania
$21.6K – – –
Belvedere Trading
33
Belvedere Trading
Illinois
$11.8K +$12K +92 New
National Bank of Canada
34
National Bank of Canada
Quebec, Canada
$8.24K +$8.35K +64 New
TAM
35
Tucker Asset Management
Colorado
$5.02K +$5.09K +39 New
CPG
36
Cornerstone Planning Group
New Jersey
$4.41K -$130 -1 -3%
PS
37
PayPay Securities
Japan
$3.48K -$10.7K -82 -75%
TFA
38
Toth Financial Advisory
Virginia
$2.58K -$5.22K -40 -67%
AWM
39
Activest Wealth Management
Florida
$2.58K – – –
HCM
40
Hollencrest Capital Management
California
$2.06K +$783 +6 +60%
US Bancorp
41
US Bancorp
Minnesota
$1.93K – – –
FFC
42
First Financial Corp
Indiana
$1.93K +$1.96K +15 New
Bank of Montreal
43
Bank of Montreal
Ontario, Canada
$1.59K +$1.57K +12 New
HF
44
HRT Financial
New York
– -$7.23M -63,762 Closed
UBS Group
45
UBS Group
Switzerland
– -$496K -4,372 Closed
TSS
46
Two Sigma Securities
New York
– -$415K -3,657 Closed
Qube Research & Technologies (QRT)
47
Qube Research & Technologies (QRT)
United Kingdom
– -$299K -2,639 Closed
HT
48
Headlands Technologies
Illinois
– -$67.6K -596 Closed
MM
49
Main Management
California
– -$1K -5 Closed
RWMG
50
Redwood Wealth Management Group
New Jersey
– -$567 -5 Closed
1
2

LABU Hedge Fund Activity: Q3 2024 in Review

43 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q3 2024, worth a combined $51.9M — down 8.6% from $56.8M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new LABU positions and 7 closed out — a net gain of 7 holders — while 7 added to existing stakes and 17 trimmed.

The largest buyer was Quadrature Capital, opening a new position worth an estimated $9.41M. The largest seller was Bank of America, cutting an estimated $7.7M.

  • 43 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q3 2024, up from 36 in Q2 2024.
  • Funds reported $51.9M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q3 2024, down 8.6% quarter-over-quarter.
  • 14 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q3 2024 and 7 closed out, a net change of +7 holders.
  • The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q3 2024 was Quadrature Capital, an estimated $9.41M added.
  • The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q3 2024 was Bank of America, an estimated $7.7M sold.

Based on aggregated 13F filings for Q3 2024.